热景生物 (688068)
Beijing Hotgen Biotech Co., Ltd.
K-Line Chart
No K-line data available
Company NameBeijing Hotgen Biotech Co., Ltd.
Listing Date2019-09-30
Issue Price29.46RMB
Registered Capital9270.79410k RMB
Legal RepresentativeLin Changqing
Registered AddressFloors 1-5, Building 7, No. 55 Yard, Qingfeng West Road, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of in vitro diagnostic reagents and instruments
Company ProfileThrough years of continuous technological R&D, Beijing Hotgen Biotech Co., Ltd. has established a core R&D technology platform based on up-conversion luminescence technology, magnetic particle chemiluminescence technology, glycocapture technology, and gene recombination & monoclonal antibody technology. It has developed a series of in vitro diagnostic reagents and instruments applicable to full-scenario immunoassays. Among these, the up-conversion luminescence technology pioneered the application of up-conversion phosphor (UCP) composed of rare earth elements in clinical and biosafety fields, and won the Second Prize of National Technology Invention Award in 2015.
Stock Details
1. Key Indicators
- Total Shares(W): N/A
- Circulating A-Shares(W): N/A
- Earnings Per Share(RMB): N/A
- Net Assets Per Share(RMB): N/A
- Operating Revenue(W RMB): N/A
- Total Profit(W RMB): N/A
- Net Profit Attributable to Parent(W RMB): N/A
- Net Profit Growth Rate(%): N/A
- Weighted Return on Equity(%): N/A
- Operating Cash Flow Per Share(RMB): N/A
- Undistributed Profit Per Share(RMB): N/A
- Capital Reserve Per Share(RMB): N/A
2. Main Business
The main business covers:
- No information available
3. Company Basic Information
- Company Name: N/A
- Listing Date: N/A
- Industry: N/A
- Address: N/A
- Website: N/A
- Company Profile: N/A
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Beijing Hotgen Biotech Co., Ltd. Special Securities Account for Repurchase | Corporate | 387.41 | 4.18 |
| 2 | ChinaAMC Innovative Medicine Theme Mixed Securities Investment Fund Class A | Fund | 268.38 | 2.89 |
| 3 | Qingdao Tongcheng Rejing Enterprise Management Consulting Partnership (Limited Partnership) | Corporate | 241.14 | 2.60 |
| 4 | ICBC Credit Suisse Frontier Healthcare Equity Securities Investment Fund Class A | Fund | 200.01 | 2.16 |
| 5 | E Fund Health Care Industry Mixed Securities Investment Fund Class A | Fund | 175.23 | 1.89 |
| 6 | Beijing Hotgen Biotech Co., Ltd. - 2024 Employee Stock Ownership Plan | Asset Management Plan | 171.69 | 1.85 |
| 7 | Basic Pension Insurance Fund 16022 Portfolio | Social Security Fund | 150.01 | 1.62 |
| 8 | E Fund Pharmaceutical and Biological Equity Securities Investment Fund Class A | Fund | 133.42 | 1.44 |
| 9 | ChinaAMC Medical Service Flexible Allocation Mixed Securities Investment Fund Class A | Fund | 108.98 | 1.18 |
| 10 | Great Wall Pharmaceutical Industry Selected Mixed Initiation Securities Investment Fund Class A | Fund | 94.75 | 1.02 |
5. Concept Sectors
- Food Safety
- Artificial Intelligence
- Hepatitis Concept
- Innovative Drugs
- AI Healthcare
- Margin Trading & Securities Lending
- Heavily Held by Funds
- Consecutive Losses
- High-Priced Stocks (Over 100 RMB)
- New Social Security Holdings
- Special Loans
- STAR Market Biotech
- STAR 200 Index
- SSE 580 Index
Remarks
- Data update date: 2025-09-30
- Data source: Public market information